Glang Le Thanh

Title: Glang Le Thanh: Innovator in Therapeutic Agent Identification

Introduction

Glang Le Thanh is a notable inventor based in Queensland, Australia. He has made significant contributions to the field of pharmacology, particularly in the identification of therapeutic agents that interact with G-Protein Coupled Receptors (GPCRs). His innovative work has the potential to impact drug development and treatment methodologies.

Latest Patents

Glang Le Thanh holds 1 patent related to his research. The patent, titled "Classes of compounds that interact with GPCRs," describes a method for identifying candidate therapeutic agents. This method involves contacting a GPCR with a compound of General Formula (I) or a pharmaceutically acceptable salt thereof. The process determines whether the compound inhibits or affects the signal transduction activity of the GPCR, identifying compounds that could serve as candidate therapeutic agents.

Career Highlights

Glang Le Thanh is currently associated with Alchemia Limited, a company focused on developing innovative therapies. His work at Alchemia Limited has allowed him to explore the intersection of chemistry and biology, leading to advancements in therapeutic agent identification.

Collaborations

Glang has collaborated with notable colleagues, including Judy Halliday and Johannes Zuegg. These collaborations have fostered a productive environment for innovation and research, contributing to the advancement of their shared goals in therapeutic development.

Conclusion

Glang Le Thanh's contributions to the field of pharmacology through his patent on GPCR interactions highlight his role as an innovator in therapeutic agent identification. His work continues to pave the way for future advancements in drug development.